T2 Biosystems, Inc. (TTOO)
0.001
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
T2 Biosystems Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.618 |
| June 30, 2024 | -3.259 |
| March 31, 2024 | -1.310 |
| December 31, 2023 | -1.766 |
| September 30, 2023 | -2.572 |
| June 30, 2023 | -1.633 |
| March 31, 2023 | -1.190 |
| December 31, 2022 | -1.493 |
| September 30, 2022 | -1.884 |
| June 30, 2022 | -1.564 |
| March 31, 2022 | -2.281 |
| December 31, 2021 | -4.520 |
| September 30, 2021 | -23.54 |
| June 30, 2021 | 6.396 |
| March 31, 2021 | -101.20 |
| December 31, 2020 | 6.523 |
| September 30, 2020 | 2.676 |
| June 30, 2020 | -10.70 |
| March 31, 2020 | -6.078 |
| December 31, 2019 | -1.375 |
| September 30, 2019 | -1.797 |
| June 30, 2019 | -3.049 |
| Date | Value |
|---|---|
| March 31, 2019 | -30.13 |
| December 31, 2018 | 3.721 |
| September 30, 2018 | 1.779 |
| June 30, 2018 | 1.317 |
| March 31, 2018 | -4.155 |
| December 31, 2017 | 31.12 |
| September 30, 2017 | 2.290 |
| June 30, 2017 | 3.349 |
| March 31, 2017 | 1.578 |
| December 31, 2016 | 1.036 |
| September 30, 2016 | 0.6473 |
| June 30, 2016 | 1.536 |
| March 31, 2016 | 0.8696 |
| December 31, 2015 | 0.6539 |
| September 30, 2015 | 0.8719 |
| June 30, 2015 | 0.6116 |
| March 31, 2015 | 0.4805 |
| December 31, 2014 | 0.3954 |
| September 30, 2014 | 0.1794 |
| June 30, 2014 | 0.4333 |
| March 31, 2014 | 0.2784 |
| December 31, 2013 | 0.2174 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| STRATA Skin Sciences, Inc. | 5.594 |
| Omnia Wellness, Inc. | -- |
| ABVC BioPharma, Inc. | 0.2807 |
| Anika Therapeutics, Inc. | 0.1839 |
| Perspective Therapeutics, Inc. | 0.0122 |